Other studies on Huntington’s disease (HD), a neurodegenerative disorder, NF-κB pathway can impair astrocyte function, and the treatment of intravenously injection of mesenchymal stem cells can improve the glymphatic transport via modulation of the NF-κB activity (Wu et al., 2020). Here, NFKB1 is linked to juvenile Huntington disease.